Francesca Blythe#454

Francesca Blythe

Partner, Sidley Austin
FRANCESCA BLYTHE advises international clients on a wide range of data protection, privacy, cybersecurity, and emerging technology issues. She has in-depth experience across multiple industries, including asset management and private equity, payments, technology, retail, e-commerce, and manufacturing. Francesca has a particular focus on life sciences, where she advises on a broad range of issues in relation to clinical studies/investigations, secondary research, digital health, and use of novel technologies (including artificial intelligence). Francesca co-leads Sidley’s benchmarking group for in-house data privacy professionals (dplegal) in the life sciences sector.

Francesca was previously in-house counsel at the largest international health and beauty retailer in Asia and Europe. While there, she regularly gave advice on compliance and strategies relating to data protection laws and assisted in the planning and delivery of a global privacy compliance project.

Contributed to

2

Conducting clinical research—data protection implications
Conducting clinical research—data protection implications
Practice Notes

This Practice Note explores the data protection implications of conducting clinical research. In particular, this Practice Note considers the responsibility for data protection compliance in the context of clinical research, the relevant legal grounds for processing personal data for research purposes, transparency requirements, collaborative research and data sharing as well as exceptions to data subject rights when processing personal data in the context of research. Finally, this Practice Note provides a checklist of practical data protection considerations to bear in mind when planning research activities.

mHealth—data protection considerations
mHealth—data protection considerations
Practice Notes

Digital health developers, manufacturers and distributors of mobile health (mHealth) apps, and any connected software as medical devices (SaMD) or artificial intelligence (AI) system, must comply with significant data protection regulations in parallel with regulatory compliance throughout the life cycle of an app’s development and commercialisation to market. This Practice Note focuses on the data protection and privacy considerations for mHealth apps, devices or connected medical software (SaMD) in the UK and EEA. mHealth, like telehealth, is a subset of eHealth under the digital health umbrella and refers to the use of mobile applications to allow users to monitor, evaluate and improve their health using mobile devices. Further discussion addresses the more stringent protections required for health data referred to as ‘special category’ data or ‘sensitive’ personal data.

Practice Area

Panel

  • Contributing Author

Qualified Year

  • 2008

Membership

  • WIP
  • IAPP (International Association of Privacy Professionals)

Qualifications

  • LLB (2008)
  • Graduate Diploma in Law (2009)

Education

  • University of Nottingham, B.Sc. (2008)
  • BPP University Law School (2009)

If you expected to see yourself on this page, click here.